Bausch & Lomb Corp (BLCO) stock
BLCONYSEOphthalmic GoodsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 9/3026% below fair value
$21.09−0.05 (-0.24%)
Close on Nov 13, 2026Market cap $7.54BP/E –Yield –
Bausch & Lomb ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Bausch & Lomb's ebitda for the twelve months ending Sep 30, 2026 was $787.00M, up 52.5% year over year. For fiscal 2025 it was $534.00M, down 10.7% from the year before. The highest annual figure on record is $744.00M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $534.00M | -10.7% |
| FY2024 | Dec 31, 2024 | $598.00M | +16.8% |
| FY2023 | Dec 31, 2023 | $512.00M | -12.6% |
| FY2022 | Dec 31, 2022 | $586.00M | -21.2% |
| FY2021 | Dec 31, 2021 | $744.00M | +6.0% |
| FY2020 | Dec 31, 2020 | $702.00M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $257.00M | +26.0% |
| Q2 FY2026 | Jun 30, 2026 | $185.00M | +92.7% |
| Q1 FY2026 | Mar 31, 2026 | $134.00M | +482.6% |
| Q4 FY2025 | Dec 31, 2025 | $211.00M | +9.3% |
| Q3 FY2025 | Sep 30, 2025 | $204.00M | +33.3% |
| Q2 FY2025 | Jun 30, 2025 | $96.00M | -29.4% |
| Q1 FY2025 | Mar 31, 2025 | $23.00M | -80.2% |
| Q4 FY2024 | Dec 31, 2024 | $193.00M | +17.0% |
| Q3 FY2024 | Sep 30, 2024 | $153.00M | +25.4% |
| Q2 FY2024 | Jun 30, 2024 | $136.00M | 0.0% |
| Q1 FY2024 | Mar 31, 2024 | $116.00M | +30.3% |
| Q4 FY2023 | Dec 31, 2023 | $165.00M | +14.6% |
| Q3 FY2023 | Sep 30, 2023 | $122.00M | -12.2% |
| Q2 FY2023 | Jun 30, 2023 | $136.00M | -11.7% |
| Q1 FY2023 | Mar 31, 2023 | $89.00M | -40.3% |
| Q4 FY2022 | Dec 31, 2022 | $144.00M | -25.0% |
| Q3 FY2022 | Sep 30, 2022 | $139.00M | -27.6% |
| Q2 FY2022 | Jun 30, 2022 | $154.00M | -8.9% |
| Q1 FY2022 | Mar 31, 2022 | $149.00M | -22.0% |
| Q4 FY2021 | Dec 31, 2021 | $192.00M | – |
| Q3 FY2021 | Sep 30, 2021 | $192.00M | – |
| Q2 FY2021 | Jun 30, 2021 | $169.00M | – |
| Q1 FY2021 | Mar 31, 2021 | $191.00M | – |
See a number that looks wrong?